
CryoLife, Inc. Long-Term Debt 2011-2026 | CRY
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt CryoLife, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 290 M | 215 M | 216 M | 218 M | 67 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 290 M | 67 M | 201 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Globus Medical
GMED
|
436 K | $ 90.0 | 1.58 % | $ 12.2 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
1.72 B | $ 11.94 | -1.08 % | $ 1.61 B | ||
|
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | ||
|
Helius Medical Technologies
HSDT
|
12 K | $ 1.83 | -3.68 % | $ 1.11 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
760 M | $ 9.33 | 0.21 % | $ 719 M | ||
|
ClearPoint Neuro
CLPT
|
49.1 M | $ 9.07 | -3.3 % | $ 257 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
2.06 B | $ 36.67 | -0.19 % | $ 5.46 K | ||
|
IRIDEX Corporation
IRIX
|
98 K | $ 1.03 | 3.35 % | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
1.19 B | $ 85.11 | -0.61 % | $ 2.96 B | ||
|
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 15.76 | -1.13 % | $ 370 M | ||
|
LENSAR
LNSR
|
1.99 M | $ 5.63 | -4.41 % | $ 67.3 M | ||
|
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | ||
|
Medtronic PLC
MDT
|
25.6 B | $ 86.42 | 0.15 % | $ 111 B | ||
|
FONAR Corporation
FONR
|
155 K | $ 18.58 | -0.11 % | $ 122 M | ||
|
Myomo
MYO
|
11.2 M | $ 0.68 | -3.62 % | $ 28.5 M | ||
|
EDAP TMS S.A.
EDAP
|
2 M | $ 3.4 | -1.73 % | $ 127 M | ||
|
Orthofix Medical
OFIX
|
157 M | $ 11.71 | -0.51 % | $ 464 M | ||
|
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
88.2 M | $ 166.87 | -2.91 % | $ 12.5 B | ||
|
AxoGen
AXGN
|
48.4 M | $ 30.99 | -5.06 % | $ 1.43 B | ||
|
Insulet Corporation
PODD
|
931 M | $ 202.46 | -0.51 % | $ 14.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | ||
|
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
2.84 M | $ 2.66 | 5.14 % | $ 7.38 M | ||
|
Smith & Nephew plc
SNN
|
3.2 B | $ 31.73 | -2.74 % | $ 23.8 B | ||
|
Stryker Corporation
SYK
|
14.9 B | $ 332.07 | -0.1 % | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
16 M | $ 24.05 | -2.12 % | $ 550 M | ||
|
Butterfly Network
BFLY
|
20.4 M | $ 4.05 | -1.94 % | $ 857 M | ||
|
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | ||
|
Tandem Diabetes Care
TNDM
|
310 M | $ 18.28 | -4.64 % | $ 1.24 B | ||
|
Cytosorbents Corporation
CTSO
|
16.7 M | $ 0.61 | 3.37 % | $ 38 M | ||
|
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
835 K | $ 9.67 | -0.31 % | $ 346 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
11.1 B | $ 61.86 | -1.17 % | $ 91.6 B | ||
|
Alphatec Holdings
ATEC
|
501 M | $ 11.03 | 0.55 % | $ 1.66 B | ||
|
Varex Imaging Corporation
VREX
|
366 M | $ 10.59 | 0.28 % | $ 438 M | ||
|
CONMED Corporation
CNMD
|
834 M | $ 34.54 | 1.35 % | $ 1.07 B | ||
|
Beyond Air
XAIR
|
1.49 M | $ 0.71 | 0.14 % | $ 48.1 M |